Deutsche Bank
TXG icon

Deutsche Bank’s 10x Genomics TXG Stock Holding History

Deutsche Bank’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.24M Buy
136,693
+20,826
+18% +$546K ﹤0.01% 1347
2026
Q1 		$2.46M Buy
115,867
+14,238
+14% +$285K ﹤0.01% 1667
2025
Q4 		$1.66M Sell
101,629
-62,564
-38% -$945K ﹤0.01% 1901
2025
Q3 		$1.92M Buy
164,193
+80,346
+96% +$1.05M ﹤0.01% 1794
2025
Q2 		$971K Buy
83,847
+75,082
+857% +$684K ﹤0.01% 2107
2025
Q1 		$76.5K Sell
8,765
-1,425
-14% -$18K ﹤0.01% 3280
2024
Q4 		$146K Buy
10,190
+2,657
+35% +$41.9K ﹤0.01% 3194
2024
Q3 		$170K Buy
7,533
+479
+7% +$9.9K ﹤0.01% 3001
2024
Q2 		$137K Buy
7,054
+451
+7% +$11.8K ﹤0.01% 3005
2024
Q1 		$248K Buy
6,603
+1,259
+24% +$55.3K ﹤0.01% 2721
2023
Q4 		$299K Sell
5,344
-6,171
-54% -$269K ﹤0.01% 2653
2023
Q3 		$475K Buy
11,515
+25
+0.2% +$1.3K ﹤0.01% 2205
2023
Q2 		$642K Buy
11,490
+987
+9% +$53.4K ﹤0.01% 2231
2023
Q1 		$586K Sell
10,503
-6,991
-40% -$326K ﹤0.01% 2403
2022
Q4 		$637K Buy
17,494
+9,657
+123% +$316K ﹤0.01% 2315
2022
Q3 		$223K Sell
7,837
-3,306
-30% -$126K ﹤0.01% 2885
2022
Q2 		$505K Sell
11,143
-98,325
-90% -$5.1M ﹤0.01% 2596
2022
Q1 		$8.33M Sell
109,468
-3,659
-3% -$320K ﹤0.01% 1173
2021
Q4 		$16.9M Sell
113,127
-26,701
-19% -$4.09M 0.01% 909
2021
Q3 		$20.4M Buy
139,828
+11,417
+9% +$1.96M 0.01% 895
2021
Q2 		$25.1M Buy
128,411
+44,065
+52% +$7.97M 0.01% 828
2021
Q1 		$15.3M Buy
84,346
+16,774
+25% +$2.9M 0.01% 998
2020
Q4 		$9.57M Buy
67,572
+65,446
+3,078% +$9.5M 0.01% 1061
2020
Q3 		$265K Sell
2,126
-175,606
-99% -$18.4M ﹤0.01% 3053
2020
Q2 		$15.9M Buy
177,732
+171,779
+2,886% +$13.4M 0.01% 782
2020
Q1 		$371K Hold
5,953
– – ﹤0.01% 2629
2019
Q4 		$453K Hold
5,953
– – ﹤0.01% 2774
2019
Q3 		$300K Buy
+5,953
New +$329K ﹤0.01% 2952

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank's TXG Position: Q2 2026 in Review

Deutsche Bank increased its 10x Genomics (TXG) stake by 18% in Q2 2026, buying an estimated $546K and bringing the position to 136,693 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1347.

Deutsche Bank first reported a position in TXG in Q3 2019 and has held it in 28 quarters since. The position peaked at $25.1M in Q2 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Deutsche Bank held 136,693 shares of 10x Genomics worth $5.24M as of Q2 2026.
  • Deutsche Bank bought 20,826 10x Genomics shares in Q2 2026, an estimated $546K.
  • 10x Genomics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1347 holding.
  • Deutsche Bank first reported a position in 10x Genomics in Q3 2019 and has held it in 28 quarters since.
  • Deutsche Bank's 10x Genomics position peaked at $25.1M in Q2 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.